Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Return on Equity (2016 - 2025)

Perspective Therapeutics' Return on Equity history spans 14 years, with the latest figure at 0.0% for Q3 2025.

  • For Q3 2025, Return on Equity rose 2.0% year-over-year to 0.0%; the TTM value through Sep 2025 reached 0.0%, up 2.0%, while the annual FY2024 figure was 0.01%, 13.0% up from the prior year.
  • Return on Equity for Q3 2025 was 0.0% at Perspective Therapeutics, up from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q3 2025 and bottomed at 0.19% in Q4 2022.
  • The 5-year median for Return on Equity is 0.06% (2021), against an average of 0.07%.
  • The largest annual shift saw Return on Equity surged 55bps in 2021 before it fell -13bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.06% in 2021, then plummeted by -235bps to 0.19% in 2022, then soared by 46bps to 0.1% in 2023, then skyrocketed by 97bps to 0.0% in 2024, then soared by 166bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for CATX's Return on Equity are 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025).